These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3614989)

  • 41. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
    de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
    Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous leishmaniasis in Guatemala: isoenzyme characterization of isolates from humans.
    Navin TR; Steurer F; de Merida AM; Arana FE; Torres MF
    Am J Trop Med Hyg; 1988 Jan; 38(1):50-1. PubMed ID: 3341522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans.
    Chan MM; Grogl M; Chen CC; Bienen EJ; Fong D
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5657-61. PubMed ID: 8516314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.
    Neal RA; van Bueren J; Hooper G
    Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy for American cutaneous leishmaniasis: the efficacy of methylene blue in hamsters experimentally infected with Leishmania (Leishmania) amazonensis.
    Peloi LS; Biondo CE; Kimura E; Politi MJ; Lonardoni MV; Aristides SM; Dorea RC; Hioka N; Silveira TG
    Exp Parasitol; 2011 Aug; 128(4):353-6. PubMed ID: 21575635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antileishmanial effects of clofazimine and other antimycobacterial agents.
    Evans AT; Croft SL; Peters W; Neal RA
    Ann Trop Med Parasitol; 1989 Oct; 83(5):447-54. PubMed ID: 2619361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
    Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
    Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Metacyclics of Leishmania mexicana in the hypopharynx of Lutzomyia youngi experimentally infected].
    Rojas E; Scorza JV
    Parassitologia; 1991 Dec; 33 Suppl():493-500. PubMed ID: 1841249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of clofazimine on Leishmania promastigotes].
    Torres Idavoy D; Montalvo Alvarez AM; Finlay CM
    Rev Cubana Med Trop; 1987; 39(2):33-8. PubMed ID: 3321231
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
    Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica.
    Childs GE; Lightner LK; McKinney L; Groves MG; Price EE; Hendricks LD
    Ann Trop Med Parasitol; 1984 Feb; 78(1):25-34. PubMed ID: 6721612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The sensitivity of Leishmania species to aminosidine.
    Neal RA; Allen S; McCoy N; Olliaro P; Croft SL
    J Antimicrob Chemother; 1995 May; 35(5):577-84. PubMed ID: 7592170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
    Berman JD
    J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
    [No Abstract]   [Full Text] [Related]  

  • 55. Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis [corrected].
    Desjeux P; Mollinedo S; Le Pont F; Paredes A; Ugarte G
    Trans R Soc Trop Med Hyg; 1987; 81(5):742-6. PubMed ID: 3449990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis.
    Araujo VC; Fukutani KF; Oshiro ET; Rodrigues PO; Rizk YS; Carollo CA; Arruda CC
    Exp Parasitol; 2015 Oct; 157():138-44. PubMed ID: 26234915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
    de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
    J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Difluoromethylornithine and formycin B in toxoplasmosis.
    Hofflin JM; Guptill DR; Araujo FG; Remington JS
    J Infect Dis; 1985 Nov; 152(5):1101. PubMed ID: 3930627
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.